CORC

在结果中检索

CORC

浏览/检索结果: 共106条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer 期刊论文
2019, 卷号: 118, 页码: 169-177
作者:  Huober, Jens;  Holmes, Eileen;  Baselga, Jose;  de Azambuja, Evandro;  Untch, Michael
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer 会议论文
ANNALS OF ONCOLOGY, 2019-05-01
作者:  Guan, X.;  Niu, Y.;  Liu, B.;  Li, C.;  Li, L.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor 期刊论文
2019
作者:  Liu Yuanyuan;  Wu Shafei;  Shi Xiaohua;  Luo Yufeng;  Pang Junyi
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer 期刊论文
2019, 卷号: 30
作者:  Guan, X.;  Niu, Y.;  Liu, B.;  Li, C.;  Li, L.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia 期刊论文
2019
作者:  Xu Binghe;  Kim Sung-Bae;  Inoue Kenichi;  Lee JuRueyJiuan;  Zhang Bo
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas 期刊论文
2019, 卷号: 11, 页码: 5971-5982
作者:  Kong, Xiangyi;  Zhang, Kai;  Wang, Xiangyu;  Yang, Xue;  Li, Yalun
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer 期刊论文
2019, 卷号: 15, 期号: 21, 页码: 2489-2501
作者:  Iwata Hiroji;  Masuda Norikazu;  Kim Sung-Bae;  Inoue Kenichi;  Rai Yoshiaki
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study 期刊论文
2019, 卷号: 14, 期号: 1, 页码: 35
作者:  Zhang, Huimin;  Xie, Peiling;  Li, Zhuoying;  Huang, Rong;  Feng, Weiliang
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer 期刊论文
2019, 卷号: 8, 期号: 2, 页码: 643-655
作者:  Cao, Rui;  Song, Wenping;  Ye, Cheng;  Liu, Xiujun;  Li, Liang
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature 期刊论文
2018, 卷号: 9, 期号: 12, 页码: 1788-1794
作者:  Shi, Yuequan;  Wang, Mengzhao
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace